Eudaimonia Partners’s Abbott ABT Stock Holding History

Eudaimonia Partners’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$285K	Sell	2,503 -272	-10%	-$31.2K	0.07%	204
2023 Q4	$305K	Sell	2,775 -1,666	-38%	-$166K	0.08%	184
2023 Q3	$430K	Sell	4,441 -12	-0.3%	-$1.26K	0.1%	190
2023 Q2	$485K	Sell	4,453 -70	-2%	-$7.46K	0.11%	188
2023 Q1	$458K	Sell	4,523 -3,920	-46%	-$414K	0.11%	193
2022 Q4	$927K	Sell	8,443 -2,469	-23%	-$256K	0.23%	116
2022 Q3	$1.06M	Sell	10,912 -9,936	-48%	-$1.06M	0.27%	95
2022 Q2	$2.27M	Sell	20,848 -5,077	-20%	-$577K	0.42%	65
2022 Q1	$3.07M	Buy	+25,925	New	+$3.21M	0.52%	49
2021 Q3	$2.64M	Buy	22,356 +88	+0.4%	+$10.8K	0.48%	58
2021 Q2	$2.58M	Buy	22,268 +463	+2%	+$54K	0.48%	55
2021 Q1	$2.61M	Sell	21,805 -3,574	-14%	-$423K	0.54%	46
2020 Q4	$2.78M	Buy	25,379 +400	+2%	+$43.5K	0.62%	38
2020 Q3	$2.72M	Buy	24,979 +5,379	+27%	+$546K	0.7%	32
2020 Q2	$1.79M	Buy	19,600 +34	+0.2%	+$3.07K	0.68%	35
2020 Q1	$1.54M	Buy	19,566 +957	+5%	+$79.9K	0.68%	37
2019 Q4	$1.62M	Buy	+18,609	New	+$1.56M	0.64%	39

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Eudaimonia Partners's ABT Position: Q1 2024 in Review

Eudaimonia Partners reduced its Abbott (ABT) stake by 9.8% in Q1 2024, selling an estimated $31.2K and leaving 2,503 shares worth $285K. The position accounts for 0.07% of the portfolio, ranked #204.

Eudaimonia Partners first reported a position in ABT in Q4 2019 and has held it in 17 quarters since. The position peaked at $3.07M in Q1 2022. 2,904 funds tracked by Wall St. Rank hold ABT as of Q1 2024.

Eudaimonia Partners held 2,503 shares of Abbott worth $285K as of Q1 2024.
Eudaimonia Partners sold 272 Abbott shares in Q1 2024, an estimated $31.2K.
Abbott made up 0.07% of Eudaimonia Partners's portfolio in Q1 2024, its #204 holding.
Eudaimonia Partners first reported a position in Abbott in Q4 2019 and has held it in 17 quarters since.
Eudaimonia Partners's Abbott position peaked at $3.07M in Q1 2022.
2,904 funds tracked by Wall St. Rank held Abbott as of Q1 2024.

Based on Eudaimonia Partners's 13F filing for Q1 2024, filed 25 Apr 2024.